Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Audit Trail Review

Posted on By

Standard Operating Procedure for Audit Trail Review

Purpose

The purpose of this SOP is to establish procedures for the periodic review and verification of audit trails within the pharmaceutical manufacturing facility. The audit trail review ensures data integrity and compliance with regulatory requirements.

Scope

This SOP applies to all personnel involved in the manufacturing, quality control, and quality assurance of pharmaceutical products, including operators, technicians, and quality assurance personnel.

Responsibilities

  • Quality Assurance Personnel: Responsible for conducting periodic reviews of audit trails and ensuring compliance with data integrity principles.
  • Operators and Technicians: Responsible for providing access to audit trails and promptly addressing any deviations identified during the review.
See also  SOP for Data Integrity Incident Reporting

Procedure

  1. Scheduled Review: Perform a scheduled review of audit trails for all relevant electronic systems, ensuring the frequency aligns with regulatory requirements and the criticality of the system.
  2. Audit Trail Accessibility: Ensure that audit trails are accessible to authorized personnel, including Quality Assurance, and that the data is presented in a readable and understandable format.
  3. Review Criteria: Establish specific criteria for the audit trail review, including but not limited to:
    • Identification of critical events and changes.
    • Review of user access and permissions.
    • Identification of unauthorized access or changes.
    • Timeliness and completeness of the audit trail.
  4. Documentation: Document the audit trail review findings, including any identified deviations or anomalies. Deviations should
be classified based on severity and potential impact.
  • Investigation of Deviations: If deviations are identified, initiate a thorough investigation to determine the root cause and assess the impact on data integrity and product quality.
  • Corrective Actions: Develop and implement corrective actions to address the root cause of identified deviations and prevent their recurrence.
  • Effectiveness Check: Conduct an effectiveness check to verify the successful implementation of corrective actions and assess whether the audit trail continues to meet regulatory requirements.
  • Documentation of Corrective Actions: Document all corrective actions taken, including updates to procedures, training records, and any changes made to prevent similar deviations in the future.
  • Archiving: Archive audit trail review records in accordance with established retention policies.
  • Abbreviations

    No abbreviations are used in this SOP.

    Documents

    • Audit Trail Review Logbook
    • Deviation Investigation Report
    • Corrective Action Plan
    • Effectiveness Check Records

    Reference

    ICH Q9 – Quality Risk Management

    SOP Version

    Version 1.0

    See also  SOP for Data Lifecycle Management
    Data Integrity Tags:Data accuracy, Data assurance, Data audit, Data confidentiality, Data consistency, Data encryption, Data governance, Data protection, Data quality, Data reliability, Data security, Data transparency, Data validation, Data verification, Database integrity, Information assurance, Information integrity, Trustworthy data

    Post navigation

    Previous Post: SOP for Deviation and Corrective Action
    Next Post: SOP for Data Retention and Archiving

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version